{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T06:37:39Z","timestamp":1793342259537,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Major Program of the National Natural Science Foundation of China","award":["82293630"],"award-info":[{"award-number":["82293630"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300243"],"award-info":[{"award-number":["82300243"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Municipal Health Commission project","award":["BRWEP2024W134080115"],"award-info":[{"award-number":["BRWEP2024W134080115"]}]},{"name":"Beijing Natural Science Foundation General Project","award":["7252142"],"award-info":[{"award-number":["7252142"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06833-4","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T10:33:47Z","timestamp":1752489227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Abnormal metabolic activation of CD8+ T cells correlates with poor prognosis in acute myeloid leukemia"],"prefix":"10.1186","volume":"23","author":[{"given":"Bixia","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinya","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingrui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huidong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"key":"6833_CR1","doi-asserted-by":"publisher","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A, Cancer statistics. CA Cancer J Clin 2022;72(1):7\u201333 https:\/\/doi.org\/10.3322\/caac.21708","DOI":"10.3322\/caac.21708"},{"issue":"12","key":"6833_CR2","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345\u201377. https:\/\/doi.org\/10.1182\/blood.2022016867.","journal-title":"Blood"},{"issue":"15","key":"6833_CR3","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1056\/NEJMp078166","volume":"357","author":"FR Appelbaum","year":"2007","unstructured":"Appelbaum FR. Hematopoietic-cell transplantation at 50. N Engl J Med. 2007;357(15):1472\u20135. https:\/\/doi.org\/10.1056\/NEJMp078166.","journal-title":"N Engl J Med"},{"issue":"25","key":"6833_CR4","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1182\/blood-2015-02-627786","volume":"125","author":"Y Wang","year":"2015","unstructured":"Wang Y, Liu QF, Xu LP, Liu KY, Zhang XH, Ma X, et al. Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study. Blood. 2015;125(25):3956\u201362. https:\/\/doi.org\/10.1182\/blood-2015-02-627786.","journal-title":"Blood"},{"issue":"23","key":"6833_CR5","doi-asserted-by":"publisher","first-page":"5584","DOI":"10.1182\/blood-2011-11-389809","volume":"119","author":"XJ Huang","year":"2012","unstructured":"Huang XJ, Zhu HH, Chang YJ, Xu LP, Liu DH, Zhang XH, et al. The superiority of haploidentical related stem cell transplantation over chemotherapy alone as postremission treatment for patients with intermediate- or high-risk acute myeloid leukemia in first complete remission. Blood. 2012;119(23):5584\u201390. https:\/\/doi.org\/10.1182\/blood-2011-11-389809.","journal-title":"Blood"},{"issue":"1","key":"6833_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13045-021-01159-2","volume":"14","author":"XH Zhang","year":"2021","unstructured":"Zhang XH, Chen J, Han MZ, Huang H, Jiang EL, Jiang M, et al. The consensus from the Chinese society of hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update. J Hematol Oncol. 2021;14(1):145. https:\/\/doi.org\/10.1186\/s13045-021-01159-2.","journal-title":"J Hematol Oncol"},{"issue":"5","key":"6833_CR7","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/s41423-020-00597-1","volume":"18","author":"H Guo","year":"2021","unstructured":"Guo H, Chang YJ, Hong Y, Xu LP, Wang Y, Zhang XH, et al. Dynamic immune profiling identifies the stronger graft-versus-leukemia (GVL) effects with haploidentical allografts compared to HLA-matched stem cell transplantation. Cell Mol Immunol. 2021;18(5):1172\u201385. https:\/\/doi.org\/10.1038\/s41423-020-00597-1.","journal-title":"Cell Mol Immunol"},{"issue":"39","key":"6833_CR8","doi-asserted-by":"publisher","first-page":"e2400544","DOI":"10.1002\/advs.202400544","volume":"11","author":"H Guo","year":"2024","unstructured":"Guo H, Guo L, Wang B, Jiang X, Wu Z, Mo XD, et al. Distinct immune homeostasis remodeling patterns after HLA-Matched and haploidentical transplantation. Adv Sci (Weinh). 2024;11(39):e2400544. https:\/\/doi.org\/10.1002\/advs.202400544.","journal-title":"Adv Sci (Weinh)"},{"issue":"9","key":"6833_CR9","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1182\/blood.2019001982","volume":"136","author":"S DeWolf","year":"2020","unstructured":"DeWolf S, Tallman MS. How I treat relapsed or refractory AML. Blood. 2020;136(9):1023\u201332. https:\/\/doi.org\/10.1182\/blood.2019001982.","journal-title":"Blood"},{"issue":"1","key":"6833_CR10","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12943-023-01889-6","volume":"22","author":"T Sauerer","year":"2023","unstructured":"Sauerer T, Vel\u00e1zquez GF, Schmid C. Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy. Mol Cancer. 2023;22(1):180. https:\/\/doi.org\/10.1186\/s12943-023-01889-6.","journal-title":"Mol Cancer"},{"issue":"3","key":"6833_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","volume":"21","author":"D Hanahan","year":"2012","unstructured":"Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012;21(3):309\u201322. https:\/\/doi.org\/10.1016\/j.ccr.2012.02.022.","journal-title":"Cancer Cell"},{"key":"6833_CR12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.critrevonc.2016.04.020","volume":"103","author":"R Austin","year":"2016","unstructured":"Austin R, Smyth MJ, Lane SW. Harnessing the immune system in acute myeloid leukaemia. Crit Rev Oncol Hematol. 2016;103:62\u201377. https:\/\/doi.org\/10.1016\/j.critrevonc.2016.04.020.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"6833_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1200\/jco.20.00475","volume":"39","author":"S Khaldoyanidi","year":"2021","unstructured":"Khaldoyanidi S, Nagorsen D, Stein A, Ossenkoppele G, Subklewe M. Immune biology of acute myeloid leukemia: implications for immunotherapy. J Clin Oncol. 2021;39(5):419\u201332. https:\/\/doi.org\/10.1200\/jco.20.00475.","journal-title":"J Clin Oncol"},{"issue":"26","key":"6833_CR14","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1182\/blood.2023019961","volume":"143","author":"J Vadakekolathu","year":"2024","unstructured":"Vadakekolathu J, Rutella S. Escape from T-cell-targeting immunotherapies in acute myeloid leukemia. Blood. 2024;143(26):2689\u2013700. https:\/\/doi.org\/10.1182\/blood.2023019961.","journal-title":"Blood"},{"issue":"6","key":"6833_CR15","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","volume":"176","author":"P van Galen","year":"2019","unstructured":"van Galen P, Hovestadt V, Wadsworth Ii MH, Hughes TK, Griffin GK, Battaglia S, et al. Single-Cell RNA-Seq reveals AML hierarchies relevant to disease progression and immunity. Cell. 2019;176(6):1265\u2013e8124. https:\/\/doi.org\/10.1016\/j.cell.2019.01.031.","journal-title":"Cell"},{"key":"6833_CR16","doi-asserted-by":"publisher","unstructured":"Perzolli A, Koedijk JB, Zwaan CM, Heidenreich O, Leukemia. 2024;38(6):1191\u2013201 https:\/\/doi.org\/10.1038\/s41375-024-02217-7","DOI":"10.1038\/s41375-024-02217-7"},{"key":"6833_CR17","doi-asserted-by":"publisher","unstructured":"Rutella S, Vadakekolathu J, Mazziotta F, Reeder S, Yau TO, Mukhopadhyay R, et al. Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia. J Clin Invest. 2022;132(21). https:\/\/doi.org\/10.1172\/jci159579.","DOI":"10.1172\/jci159579"},{"issue":"1","key":"6833_CR18","doi-asserted-by":"publisher","first-page":"6209","DOI":"10.1038\/s41467-023-41994-0","volume":"14","author":"H Mumme","year":"2023","unstructured":"Mumme H, Thomas BE, Bhasin SS, Krishnan U, Dwivedi B, Perumalla P, et al. Single-cell analysis reveals altered tumor microenvironments of relapse- and remission-associated pediatric acute myeloid leukemia. Nat Commun. 2023;14(1):6209. https:\/\/doi.org\/10.1038\/s41467-023-41994-0.","journal-title":"Nat Commun"},{"issue":"1","key":"6833_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s43018-022-00480-0","volume":"4","author":"A Lasry","year":"2023","unstructured":"Lasry A, Nadorp B, Fornerod M, Nicolet D, Wu H, Walker CJ, et al. An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia. Nat Cancer. 2023;4(1):27\u201342. https:\/\/doi.org\/10.1038\/s43018-022-00480-0.","journal-title":"Nat Cancer"},{"issue":"1","key":"6833_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40364-021-00265-0","volume":"9","author":"R Guo","year":"2021","unstructured":"Guo R, L\u00fc M, Cao F, Wu G, Gao F, Pang H, et al. Single-cell map of diverse immune phenotypes in the acute myeloid leukemia microenvironment. Biomark Res. 2021;9(1):15. https:\/\/doi.org\/10.1186\/s40364-021-00265-0.","journal-title":"Biomark Res"},{"issue":"2","key":"6833_CR21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41590-023-01733-5","volume":"25","author":"D Wilfahrt","year":"2024","unstructured":"Wilfahrt D, Delgoffe GM. Metabolic waypoints during T cell differentiation. Nat Immunol. 2024;25(2):206\u201317. https:\/\/doi.org\/10.1038\/s41590-023-01733-5.","journal-title":"Nat Immunol"},{"issue":"4","key":"6833_CR22","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.cell.2017.04.004","volume":"169","author":"MD Buck","year":"2017","unstructured":"Buck MD, Sowell RT, Kaech SM, Pearce EL. Metabolic Instruction Immun Cell. 2017;169(4):570\u201386. https:\/\/doi.org\/10.1016\/j.cell.2017.04.004.","journal-title":"Metabolic Instruction Immun Cell"},{"issue":"1","key":"6833_CR23","doi-asserted-by":"publisher","first-page":"6858","DOI":"10.1038\/s41467-023-42634-3","volume":"14","author":"H Wu","year":"2023","unstructured":"Wu H, Zhao X, Hochrein SM, Eckstein M, Gubert GF, Kn\u00f6pper K, et al. Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1\u03b1-mediated glycolytic reprogramming. Nat Commun. 2023;14(1):6858. https:\/\/doi.org\/10.1038\/s41467-023-42634-3.","journal-title":"Nat Commun"},{"key":"6833_CR24","doi-asserted-by":"publisher","first-page":"100786","DOI":"10.1016\/j.blre.2020.100786","volume":"48","author":"B Xu","year":"2021","unstructured":"Xu B, Hu R, Liang Z, Chen T, Chen J, Hu Y, et al. Metabolic regulation of the bone marrow microenvironment in leukemia. Blood Rev. 2021;48:100786. https:\/\/doi.org\/10.1016\/j.blre.2020.100786.","journal-title":"Blood Rev"},{"key":"6833_CR25","doi-asserted-by":"publisher","unstructured":"Uhl FM, Chen S, O\u2019Sullivan D, Edwards-Hicks J, Richter G, Haring E, et al. Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans. Sci Transl Med. 2020;12(567). https:\/\/doi.org\/10.1126\/scitranslmed.abb8969.","DOI":"10.1126\/scitranslmed.abb8969"},{"issue":"6614","key":"6833_CR26","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1126\/science.abj5104","volume":"377","author":"G Notarangelo","year":"2022","unstructured":"Notarangelo G, Spinelli JB, Perez EM, Baker GJ, Kurmi K, Elia I, et al. Oncometabolite d-2HG alters T cell metabolism to impair CD8(+) T cell function. Science. 2022;377(6614):1519\u201329. https:\/\/doi.org\/10.1126\/science.abj5104.","journal-title":"Science"},{"issue":"16","key":"6833_CR27","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1056\/NEJMoa2117344","volume":"386","author":"P Montesinos","year":"2022","unstructured":"Montesinos P, Recher C, Vives S, Zarzycka E, Wang J, Bertani G, et al. Ivosidenib and Azacitidine in IDH1-Mutated acute myeloid leukemia. N Engl J Med. 2022;386(16):1519\u201331. https:\/\/doi.org\/10.1056\/NEJMoa2117344.","journal-title":"N Engl J Med"},{"issue":"1","key":"6833_CR28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s40164-022-00332-8","volume":"11","author":"B Xu","year":"2022","unstructured":"Xu B, Zhou Z, Wen Y, Li Z, Huang Z, Li Y. The immunometabolic landscape of the bone marrow microenvironment in acute myeloid leukemia. Exp Hematol Oncol. 2022;11(1):81. https:\/\/doi.org\/10.1186\/s40164-022-00332-8.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"6833_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/path.5396","volume":"251","author":"L Guo","year":"2020","unstructured":"Guo L, Bi X, Li Y, Wen L, Zhang W, Jiang W, et al. Characteristics, dynamic changes, and prognostic significance of TCR repertoire profiling in patients with renal cell carcinoma. J Pathol. 2020;251(1):26\u201337. https:\/\/doi.org\/10.1002\/path.5396.","journal-title":"J Pathol"},{"issue":"15","key":"6833_CR30","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1182\/blood.2022018246","volume":"141","author":"L Penter","year":"2023","unstructured":"Penter L, Liu Y, Wolff JO, Yang L, Taing L, Jhaveri A, et al. Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease. Blood. 2023;141(15):1817\u201330. https:\/\/doi.org\/10.1182\/blood.2022018246.","journal-title":"Blood"},{"issue":"1","key":"6833_CR31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13045-017-0502-3","volume":"10","author":"YJ Chang","year":"2017","unstructured":"Chang YJ, Wang Y, Liu YR, Xu LP, Zhang XH, Chen H, et al. Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis. J Hematol Oncol. 2017;10(1):134. https:\/\/doi.org\/10.1186\/s13045-017-0502-3.","journal-title":"J Hematol Oncol"},{"issue":"5","key":"6833_CR32","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1038\/s41375-019-0686-3","volume":"34","author":"S Yu","year":"2020","unstructured":"Yu S, Huang F, Wang Y, Xu Y, Yang T, Fan Z, et al. Haploidentical transplantation might have superior graft-versus-leukemia effect than HLA-matched sibling transplantation for high-risk acute myeloid leukemia in first complete remission: a prospective multicentre cohort study. Leukemia. 2020;34(5):1433\u201343. https:\/\/doi.org\/10.1038\/s41375-019-0686-3.","journal-title":"Leukemia"},{"issue":"10","key":"6833_CR33","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1200\/jco.2012.44.3523","volume":"31","author":"A Bashey","year":"2013","unstructured":"Bashey A, Zhang X, Sizemore CA, Manion K, Brown S, Holland HK, et al. T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation. J Clin Oncol. 2013;31(10):1310\u20136. https:\/\/doi.org\/10.1200\/jco.2012.44.3523.","journal-title":"J Clin Oncol"},{"issue":"2","key":"6833_CR34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41409-022-01872-7","volume":"58","author":"M Wang","year":"2023","unstructured":"Wang M, Wang B, Xu LP, Wang Y, Zhang XH, Cheng YF, et al. The lower relapse rate and better survival advantages of haploidentical allograft compared with HLA-matched sibling donor allografts for intermediate- and adverse-risk AML patients with pretransplantation minimal residual disease. Bone Marrow Transpl. 2023;58(2):215\u20138. https:\/\/doi.org\/10.1038\/s41409-022-01872-7.","journal-title":"Bone Marrow Transpl"},{"issue":"1","key":"6833_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13045-020-00860-y","volume":"13","author":"YJ Chang","year":"2020","unstructured":"Chang YJ, Wang Y, Xu LP, Zhang XH, Chen H, Chen YH, et al. Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized study. J Hematol Oncol. 2020;13(1):27. https:\/\/doi.org\/10.1186\/s13045-020-00860-y.","journal-title":"J Hematol Oncol"},{"issue":"6","key":"6833_CR36","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1073\/pnas.1019625108","volume":"108","author":"YY Wang","year":"2011","unstructured":"Wang YY, Zhao LJ, Wu CF, Liu P, Shi L, Liang Y, et al. C-KIT mutation cooperates with full-length AML1-ETO to induce acute myeloid leukemia in mice. Proc Natl Acad Sci U S A. 2011;108(6):2450\u20135. https:\/\/doi.org\/10.1073\/pnas.1019625108.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"6833_CR37","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.cell.2023.02.015","volume":"186","author":"D Wang","year":"2023","unstructured":"Wang D, Liu B, Zhang Z. Accelerating the Understanding of cancer biology through the lens of genomics. Cell. 2023;186(8):1755\u201371. https:\/\/doi.org\/10.1016\/j.cell.2023.02.015.","journal-title":"Cell"},{"key":"6833_CR38","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1146\/annurev-immunol-110519-071134","volume":"39","author":"X Ren","year":"2021","unstructured":"Ren X, Zhang L, Zhang Y, Li Z, Siemers N, Zhang Z. Insights gained from Single-Cell analysis of immune cells in the tumor microenvironment. Annu Rev Immunol. 2021;39:583\u2013609. https:\/\/doi.org\/10.1146\/annurev-immunol-110519-071134.","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"6833_CR39","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.ccell.2024.06.009","volume":"42","author":"Y Chen","year":"2024","unstructured":"Chen Y, Wang D, Li Y, Qi L, Si W, Bo Y, et al. Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancer. Cancer Cell. 2024;42(7):1268\u2013e857. https:\/\/doi.org\/10.1016\/j.ccell.2024.06.009.","journal-title":"Cancer Cell"},{"issue":"7870","key":"6833_CR40","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41586-021-03704-y","volume":"596","author":"G Oliveira","year":"2021","unstructured":"Oliveira G, Stromhaug K, Klaeger S, Kula T, Frederick DT, Le PM, et al. Phenotype, specificity and avidity of antitumour CD8(+) T cells in melanoma. Nature. 2021;596(7870):119\u201325. https:\/\/doi.org\/10.1038\/s41586-021-03704-y.","journal-title":"Nature"},{"issue":"7870","key":"6833_CR41","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41586-021-03752-4","volume":"596","author":"JX Caushi","year":"2021","unstructured":"Caushi JX, Zhang J, Ji Z, Vaghasia A, Zhang B, Hsiue EH, et al. Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers. Nature. 2021;596(7870):126\u201332. https:\/\/doi.org\/10.1038\/s41586-021-03752-4.","journal-title":"Nature"},{"issue":"3","key":"6833_CR42","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.cell.2016.12.022","volume":"168","author":"MH Spitzer","year":"2017","unstructured":"Spitzer MH, Carmi Y, Reticker-Flynn NE, Kwek SS, Madhireddy D, Martins MM, et al. Systemic immunity is required for effective Cancer immunotherapy. Cell. 2017;168(3):487\u2013e50215. https:\/\/doi.org\/10.1016\/j.cell.2016.12.022.","journal-title":"Cell"},{"issue":"1","key":"6833_CR43","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.1038\/s41467-019-12464-3","volume":"10","author":"PA Szabo","year":"2019","unstructured":"Szabo PA, Levitin HM, Miron M, Snyder ME, Senda T, Yuan J, et al. Single-cell transcriptomics of human T cells reveals tissue and activation signatures in health and disease. Nat Commun. 2019;10(1):4706. https:\/\/doi.org\/10.1038\/s41467-019-12464-3.","journal-title":"Nat Commun"},{"issue":"4","key":"6833_CR44","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ccell.2025.03.012","volume":"43","author":"J Luo","year":"2025","unstructured":"Luo J, Solit DB. Leveraging real-world data to advance biomarker discovery and precision oncology. Cancer Cell. 2025;43(4):606\u201310. https:\/\/doi.org\/10.1016\/j.ccell.2025.03.012.","journal-title":"Cancer Cell"},{"key":"6833_CR45","doi-asserted-by":"publisher","first-page":"217264","DOI":"10.1016\/j.canlet.2024.217264","volume":"605","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chang YJ, Chen J, Han M, Hu J, Hu J, et al. Consensus on the monitoring, treatment, and prevention of leukaemia relapse after allogeneic Haematopoietic stem cell transplantation in china: 2024 update. Cancer Lett. 2024;605:217264. https:\/\/doi.org\/10.1016\/j.canlet.2024.217264.","journal-title":"Cancer Lett"},{"issue":"82","key":"6833_CR46","doi-asserted-by":"publisher","first-page":"eabq3016","DOI":"10.1126\/sciimmunol.abq3016","volume":"8","author":"JJ Peng","year":"2023","unstructured":"Peng JJ, Wang L, Li Z, Ku CL, Ho PC. Metabolic challenges and interventions in CAR T cell therapy. Sci Immunol. 2023;8(82):eabq3016. https:\/\/doi.org\/10.1126\/sciimmunol.abq3016.","journal-title":"Sci Immunol"},{"issue":"10","key":"6833_CR47","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s42255-020-00280-9","volume":"2","author":"F Franco","year":"2020","unstructured":"Franco F, Jaccard A, Romero P, Yu YR, Ho PC. Metabolic and epigenetic regulation of T-cell exhaustion. Nat Metab. 2020;2(10):1001\u201312. https:\/\/doi.org\/10.1038\/s42255-020-00280-9.","journal-title":"Nat Metab"},{"issue":"8","key":"6833_CR48","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.cmet.2022.06.008","volume":"34","author":"I Elia","year":"2022","unstructured":"Elia I, Rowe JH, Johnson S, Joshi S, Notarangelo G, Kurmi K, et al. Tumor cells dictate anti-tumor immune responses by altering pyruvate utilization and succinate signaling in CD8(+) T cells. Cell Metab. 2022;34(8):1137\u2013e506. https:\/\/doi.org\/10.1016\/j.cmet.2022.06.008.","journal-title":"Cell Metab"},{"key":"6833_CR49","doi-asserted-by":"publisher","unstructured":"Lim AR, Rathmell WK, Rathmell JC. The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy. Elife. 2020;9. https:\/\/doi.org\/10.7554\/eLife.55185.","DOI":"10.7554\/eLife.55185"},{"issue":"12","key":"6833_CR50","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-020-0793-3","volume":"21","author":"YR Yu","year":"2020","unstructured":"Yu YR, Imrichova H, Wang H, Chao T, Xiao Z, Gao M, et al. Disturbed mitochondrial dynamics in CD8(+) TILs reinforce T cell exhaustion. Nat Immunol. 2020;21(12):1540\u201351. https:\/\/doi.org\/10.1038\/s41590-020-0793-3.","journal-title":"Nat Immunol"},{"issue":"6","key":"6833_CR51","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.cell.2015.08.012","volume":"162","author":"PC Ho","year":"2015","unstructured":"Ho PC, Bihuniak JD, Macintyre AN, Staron M, Liu X, Amezquita R, et al. Phosphoenolpyruvate is a metabolic checkpoint of Anti-tumor T cell responses. Cell. 2015;162(6):1217\u201328. https:\/\/doi.org\/10.1016\/j.cell.2015.08.012.","journal-title":"Cell"},{"issue":"7858","key":"6833_CR52","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41586-021-03442-1","volume":"593","author":"BI Reinfeld","year":"2021","unstructured":"Reinfeld BI, Madden MZ, Wolf MM, Chytil A, Bader JE, Patterson AR, et al. Cell-programmed nutrient partitioning in the tumour microenvironment. Nature. 2021;593(7858):282\u20138. https:\/\/doi.org\/10.1038\/s41586-021-03442-1.","journal-title":"Nature"},{"issue":"1","key":"6833_CR53","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.immuni.2022.12.008","volume":"56","author":"J Park","year":"2023","unstructured":"Park J, Hsueh PC, Li Z, Ho PC. Microenvironment-driven metabolic adaptations guiding CD8(+) T cell anti-tumor immunity. Immunity. 2023;56(1):32\u201342. https:\/\/doi.org\/10.1016\/j.immuni.2022.12.008.","journal-title":"Immunity"},{"issue":"6","key":"6833_CR54","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","volume":"25","author":"A Angelin","year":"2017","unstructured":"Angelin A, Gil-de-G\u00f3mez L, Dahiya S, Jiao J, Guo L, Levine MH, et al. Foxp3 reprograms T cell metabolism to function in Low-Glucose, High-Lactate environments. Cell Metab. 2017;25(6):1282\u2013e937. https:\/\/doi.org\/10.1016\/j.cmet.2016.12.018.","journal-title":"Cell Metab"},{"issue":"9","key":"6833_CR55","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","volume":"109","author":"K Fischer","year":"2007","unstructured":"Fischer K, Hoffmann P, Voelkl S, Meidenbauer N, Ammer J, Edinger M, et al. Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood. 2007;109(9):3812\u20139. https:\/\/doi.org\/10.1182\/blood-2006-07-035972.","journal-title":"Blood"},{"key":"6833_CR56","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.canlet.2017.08.033","volume":"408","author":"K Voss","year":"2017","unstructured":"Voss K, Larsen SE, Snow AL. Metabolic reprogramming and apoptosis sensitivity: defining the contours of a T cell response. Cancer Lett. 2017;408:190\u20136. https:\/\/doi.org\/10.1016\/j.canlet.2017.08.033.","journal-title":"Cancer Lett"},{"issue":"1","key":"6833_CR57","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.immuni.2014.12.030","volume":"42","author":"J Blagih","year":"2015","unstructured":"Blagih J, Coulombe F, Vincent EE, Dupuy F, Galicia-V\u00e1zquez G, Yurchenko E, et al. The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo. Immunity. 2015;42(1):41\u201354. https:\/\/doi.org\/10.1016\/j.immuni.2014.12.030.","journal-title":"Immunity"},{"issue":"1","key":"6833_CR58","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13045-022-01255-x","volume":"15","author":"Y Huang","year":"2022","unstructured":"Huang Y, Si X, Shao M, Teng X, Xiao G, Huang H. Rewiring mitochondrial metabolism to counteract exhaustion of CAR-T cells. J Hematol Oncol. 2022;15(1):38. https:\/\/doi.org\/10.1186\/s13045-022-01255-x.","journal-title":"J Hematol Oncol"},{"issue":"6","key":"6833_CR59","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/s41590-021-00940-2","volume":"22","author":"Y Guo","year":"2021","unstructured":"Guo Y, Xie YQ, Gao M, Zhao Y, Franco F, Wenes M, et al. Metabolic reprogramming of terminally exhausted CD8(+) T cells by IL-10 enhances anti-tumor immunity. Nat Immunol. 2021;22(6):746\u201356. https:\/\/doi.org\/10.1038\/s41590-021-00940-2.","journal-title":"Nat Immunol"},{"issue":"9","key":"6833_CR60","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/s41590-020-0725-2","volume":"21","author":"SA Vardhana","year":"2020","unstructured":"Vardhana SA, Hwee MA, Berisa M, Wells DK, Yost KE, King B, et al. Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen. Nat Immunol. 2020;21(9):1022\u201333. https:\/\/doi.org\/10.1038\/s41590-020-0725-2.","journal-title":"Nat Immunol"},{"issue":"11","key":"6833_CR61","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1038\/s41587-023-02060-8","volume":"42","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Chen J, Andreatta M, Feng B, Xie YQ, Wenes M, et al. IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases. Nat Biotechnol. 2024;42(11):1693\u2013704. https:\/\/doi.org\/10.1038\/s41587-023-02060-8.","journal-title":"Nat Biotechnol"},{"issue":"12","key":"6833_CR62","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.tips.2006.10.005","volume":"27","author":"V Adam-Vizi","year":"2006","unstructured":"Adam-Vizi V, Chinopoulos C. Bioenergetics and the formation of mitochondrial reactive oxygen species. Trends Pharmacol Sci. 2006;27(12):639\u201345. https:\/\/doi.org\/10.1016\/j.tips.2006.10.005.","journal-title":"Trends Pharmacol Sci"},{"issue":"Pt 2","key":"6833_CR63","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1042\/bj20021121","volume":"368","author":"Y Kushnareva","year":"2002","unstructured":"Kushnareva Y, Murphy AN, Andreyev A. Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD(P)\u2009+\u2009oxidation-reduction state. Biochem J. 2002;368(Pt 2):545\u201353. https:\/\/doi.org\/10.1042\/bj20021121.","journal-title":"Biochem J"},{"key":"6833_CR64","doi-asserted-by":"publisher","first-page":"652687","DOI":"10.3389\/fimmu.2021.652687","volume":"12","author":"HY Peng","year":"2021","unstructured":"Peng HY, Lucavs J, Ballard D, Das JK, Kumar A, Wang L, et al. Metabolic reprogramming and reactive oxygen species in T cell immunity. Front Immunol. 2021;12:652687. https:\/\/doi.org\/10.3389\/fimmu.2021.652687.","journal-title":"Front Immunol"},{"issue":"3","key":"6833_CR65","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","volume":"12","author":"ED Lagadinou","year":"2013","unstructured":"Lagadinou ED, Sach A, Callahan K, Rossi RM, Neering SJ, Minhajuddin M, et al. BCL-2 Inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell. 2013;12(3):329\u201341. https:\/\/doi.org\/10.1016\/j.stem.2012.12.013.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"6833_CR66","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1007\/s10637-021-01112-7","volume":"39","author":"F Janku","year":"2021","unstructured":"Janku F, LoRusso P, Mansfield AS, Nanda R, Spira A, Wang T, et al. First-in-human evaluation of the novel mitochondrial complex I inhibitor ASP4132 for treatment of cancer. Invest New Drugs. 2021;39(5):1348\u201356. https:\/\/doi.org\/10.1007\/s10637-021-01112-7.","journal-title":"Invest New Drugs"},{"issue":"1","key":"6833_CR67","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41591-022-02103-8","volume":"29","author":"TA Yap","year":"2023","unstructured":"Yap TA, Daver N, Mahendra M, Zhang J, Kamiya-Matsuoka C, Meric-Bernstam F, et al. Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nat Med. 2023;29(1):115\u201326. https:\/\/doi.org\/10.1038\/s41591-022-02103-8.","journal-title":"Nat Med"},{"key":"6833_CR68","doi-asserted-by":"publisher","unstructured":"Li C, Phoon YP, Karlinsey K, Tian YF, Thapaliya S, Thongkum A, et al. A high OXPHOS CD8 T cell subset is predictive of immunotherapy resistance in melanoma patients. J Exp Med. 2022;219(1). https:\/\/doi.org\/10.1084\/jem.20202084.","DOI":"10.1084\/jem.20202084"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06833-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06833-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06833-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T10:33:48Z","timestamp":1752489228000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06833-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6833"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06833-4","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]},"assertion":[{"value":"11 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not involve human participants and human samples. All experiments were performed according to the National Institutes of Health\u2019s Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors have read and approved the final manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"791"}}